Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
i have alluded to my clinical background in the past without giving too much away but tocilizumab or simply "Toc" as we call it in ITU is also an immunosuppressant which is not ideal for covid patients!
wont add much more else as not needed!
https://www.google.co.uk/amp/s/www.defenceweb.co.za/featured/sandf-defends-acquisition-of-interferon-drug-from-cuba/amp/
“ “Over the last four months a lot has been reported and written about the Interferon alfa-2b or the Heberon alfa R, since the South African National Defence Force acquired the medication from Cuba on emergency basis following the outbreak of COVID-19 in March 2020. There has since been a great interest in the drug and its efficacy as an immune-modulator in mitigation of COVID-19 complications including death and need for hospitalisation,” the statement read.”
"The White House said Joe Biden has been briefed about the recent outbreak of Ebola in west and central Africa.
“While the world is reeling from the ongoing COVID-19 pandemic, Ebola has again emerged, simultaneously, in both Central and West Africa,” White House press secretary Jen Psaki said in a statement.
“The world cannot afford to turn the other way. We must do everything in our power to respond quickly, effectively, and with commensurate resources to stop these outbreaks before they become largescale epidemics.”
https://jvi.asm.org/content/77/14/7945#:~:text=The%20Ebola%20virus%20VP35%20protein%20was%20previously%20found%20to%20act,virus%20IFN%20antagonist%20protein%2C%20NS1.
The Ebola virus VP35 protein was previously found to act as an interferon (IFN) antagonist which could complement growth of influenza delNS1 virus, a mutant influenza virus lacking the influenza virus IFN antagonist protein, NS1.
https://www.sciencedaily.com/releases/2017/03/170321092637.htm
"A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival."
Just checking in...insane amount of huge buys going through and clearing big sellers along the way - nice foundations being laid at every level which bodes well for share price stability.
Chart also looking good...
atb all and please stay safe
Finally had time to sit and read through properly
completely de-risked imho...fda given fast track designation so will be looking at activ carefully now to pounce with EUA - cannot be left out of this now next few weeks.
atb all
Stating obvious I know but I Think this week could still be incredibly interesting in terms of further developments
Not sure how much of the rise on Friday was due to possible anticipation that SNG were going to be mentioned in the new drug funding - onwards and upwards anyhow